135 related articles for article (PubMed ID: 23997820)
1. Predictors of metabolic parameter monitoring in adolescents on antipsychotics in a primary care setting.
Ghate SR; Porucznik CA; Said Q; Hashibe M; Joy E; Brixner DI
Ment Health Fam Med; 2012 Sep; 9(3):137-48. PubMed ID: 23997820
[TBL] [Abstract][Full Text] [Related]
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Recommended Metabolic Monitoring of Children and Adolescents Taking Second-Generation Antipsychotics.
Sanyal S; Calarge C; Rowan PJ; Aparasu RR; Abughosh S; Sisley S; Chen H
Psychiatr Serv; 2024 Apr; 75(4):342-348. PubMed ID: 37789728
[TBL] [Abstract][Full Text] [Related]
4. Metabolic monitoring of patients prescribed second-generation antipsychotics.
Dhamane AD; Martin BC; Brixner DI; Hudson TJ; Said Q
J Psychiatr Pract; 2013 Sep; 19(5):360-74. PubMed ID: 24042242
[TBL] [Abstract][Full Text] [Related]
5. Association between second-generation antipsychotics and changes in body mass index in adolescents.
Ghate SR; Porucznik CA; Said Q; Hashibe M; Joy E; Brixner DI
J Adolesc Health; 2013 Mar; 52(3):336-43. PubMed ID: 23427784
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Monitoring of Child and Adolescent Patients on Atypical Antipsychotics by Psychiatrists and Primary Care Providers.
Wakefield S; Aligeti M; Rachamallu V; Baronia R; Aynampudi R; Parmar A; Peterson P; Masodkar K
Am J Ther; 2020; 27(5):e425-e430. PubMed ID: 30762589
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers.
Uzal NE; Chavez B; Kosirog ER; Billups SJ; Saseen JJ
Ann Pharmacother; 2018 Feb; 52(2):160-165. PubMed ID: 28884591
[TBL] [Abstract][Full Text] [Related]
9. Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents.
Sanyal S; Calarge CA; Rowan PJ; Aparasu RR; Abughosh S; Chen H
J Psychiatr Res; 2023 Sep; 165():170-173. PubMed ID: 37506412
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
[TBL] [Abstract][Full Text] [Related]
11. Monitoring veterans for metabolic side effects when prescribing antipsychotics.
Mittal D; Li C; Williams JS; Viverito K; Landes RD; Owen RR
Psychiatr Serv; 2013 Jan; 64(1):28-35. PubMed ID: 23117285
[TBL] [Abstract][Full Text] [Related]
12. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
[TBL] [Abstract][Full Text] [Related]
13. Identification of risk factors and metabolic monitoring practices in patients on antipsychotic drugs in South India.
Poojari PG; Khan SA; Shenoy S; Acharya LD; Shetty S; Bose S; Pai K; Kunhikatta V; Thunga G
Asian J Psychiatr; 2020 Oct; 53():102186. PubMed ID: 32563106
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents.
Haupt DW; Rosenblatt LC; Kim E; Baker RA; Whitehead R; Newcomer JW
Am J Psychiatry; 2009 Mar; 166(3):345-53. PubMed ID: 19147694
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
16. Metabolic monitoring of pediatric patients prescribed second-generation antipsychotic medication.
Roebuck JH
J Child Adolesc Psychiatr Nurs; 2024 Feb; 37(1):e12438. PubMed ID: 37586850
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Métabolique à Long Terme des Jeunes Traités par Antipsychotiques de Deuxième Génération, Cinq ans Après la publication des Lignes Directrices Camesa: Faisons-Nous des Progrès?
Jazi S; Ben-Amor L; Abadie P; Menard ML; Choquette R; Berthiaume C; Mottron L; Ilies D
Can J Psychiatry; 2021 Jul; 66(7):645-656. PubMed ID: 33243011
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics.
Minjon L; Brozina I; Egberts TCG; Heerdink ER; van den Ban E
Front Psychiatry; 2021; 12():640377. PubMed ID: 33716833
[No Abstract] [Full Text] [Related]
19. Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics.
Rodday AM; Parsons SK; Mankiw C; Correll CU; Robb AS; Zima BT; Saunders TS; Leslie LK
J Child Adolesc Psychopharmacol; 2015 May; 25(4):351-61. PubMed ID: 25918843
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
Pallava A; Chadda RK; Sood M; Lakshmy R
Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
